701-1363

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
701 (USA) · Dr. Reyes
consented 2013-05-30

AEs

Serious

Dropout signal

–

Adverse events

mild assessed

Mild APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-07-16 (study day 48.0); relationship: PROBABLE

mild assessed

Mild BACK PAIN — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-13 (study day 137.0); relationship: NONE

mild assessed

Mild BACK PAIN — outcome: RECOVERED/RESOLVED; onset 2013-10-13 (study day 137.0); relationship: NONE

moderate assessed

Moderate HEADACHE — outcome: NOT RECOVERED/NOT RESOLVED; onset 1986; relationship: POSSIBLE

mild assessed

Mild HEADACHE — outcome: NOT RECOVERED/NOT RESOLVED; onset 1986; relationship: POSSIBLE

mild assessed

Mild NAUSEA — outcome: RECOVERED/RESOLVED; onset 2013-06-14 (study day 16.0); relationship: REMOTE

Data queries

No data queries.